title: Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours.
abstract: Endogenous porphyrin accumulation after administration of 5-aminolevulinic acid is employed in photodynamic therapy of tumours. Due to its low membrane permeability, esterified 5-aminolevulinic acid derivatives less hydrophilic than the parental compound are under investigation. Knowledge of the mechanisms of 5-aminolevulinic acid derivatives uptake into target cells is essential to understand and improve photodynamic therapy and useful in the design of new derivatives with better affinity and with higher selectivity for tumour cells in specific tissues. The aim of this work was to assess the interaction of 5-aminolevulinic acid derivatives with the intestinal PEPT1 and renal transporter PEPT2 expressed in Pichia pastoris yeasts. We found that Undecanoyl, Hexyl, Methyl and 2-(hydroxymethyl)tetrahydropyranyl 5-aminolevulinic acid esters and the dendron 3m-ALA inhibited (14)C-5-aminolevulinic acid uptake by PEPT2. However, only the Undecanoyl ester inhibited 5-aminolevulinic acid uptake by PEPT1. We have also found through a new developed colorimetric method, that Hexyl and 2-(hydroxymethyl)tetrahydropyranyl 5-aminolevulinic acid esters display more affinity than 5-aminolevulinic acid for PEPT2 whereas none of the compounds surpass 5-aminolevulinic acid affinity for PEPT1. In addition, the Undecanoyl ester binds with high affinity to the membranes of PEPT2 and PEPT1-expressing yeasts and to the control yeasts. The main finding of this work was that some derivatives have the potential to improve 5-aminolevulinic acid-based photodynamic therapy by increased efficiency of transport into cells expressing PEPT2 such as kidney, mammary gland, brain or lung whereas in tissues expressing exclusively PEPT1 the parent 5-aminolevulinic acid remains the compound of choice.
authors.affiliation: Centro de Investigaciones sobre Porfirinas y Porfirias, CONICET and Hospital de Clínicas José de San Martín, University of Buenos Aires, Córdoba 2351 1er subsuelo, Ciudad de Buenos Aires, CP 1120AAF, Argentina.
authors.forename: Lorena
authors.initials: L
authors.lastname: Rodriguez
authors.forename: Alcira
authors.initials: A
authors.lastname: Batlle
authors.forename: Gabriela
authors.initials: G
authors.lastname: Di Venosa
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: MacRobert
authors.forename: Sinan
authors.initials: S
authors.lastname: Battah
authors.forename: Hannelore
authors.initials: H
authors.lastname: Daniel
authors.forename: Adriana
authors.initials: A
authors.lastname: Casas
mesh_terms: D000622:Aminolevulinic Acid / Q000031:analogs & derivatives / Q000378:metabolism*; D030781:Organisms, Genetically Modified / Q000378:metabolism; D000074011:Peptide Transporter 1; D010778:Photochemotherapy / Q000379:methods*; D010843:Pichia / Q000378:metabolism; D027981:Symporters / Q000378:metabolism*
chemical_list: D000074011:Peptide Transporter 1; C082186:SLC15A1 protein, human; D027981:Symporters; C093694:hydrogen-coupled oligopeptide transporter PepT2; D000622:Aminolevulinic Acid